MD Anderson Survivor Profile Credits Immunotherapy Trial in Stage IV Melanoma
A Stage IV melanoma survivor credits an immunotherapy clinical trial at UT MD Anderson. The headline carries the message, the full feature sits behind an external link, and clinicians wait for the un…